Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations.

OBJECTIVE To describe the various conditions of peripheral nerve, neuromuscular junction, and muscle associated with the systemic inflammatory response syndrome (SIRS). DATA SOURCES Publications in the scientific literature and personal observations during the last 15 yrs. DATA EXTRACTION Computer search of the literature and review of patient records relating to polyneuropathy, neuromuscular transmission defects, and myopathies associated with sepsis, the septic syndrome, and SIRS. SYNTHESIS SIRS is a new concept in which infection and trauma induce a systemic inflammatory response affecting the microcirculation to organs throughout the body. The nervous system is commonly affected in the forms of septic encephalopathy and critical illness polyneuropathy. Neuromuscular blocking agents and corticosteroids may have additional toxic effects on the neuromuscular system that are manifest as transient neuromuscular blockade, an axonal motor neuropathy, or a thick filament myopathy. Clinical examination in the critical care unit is often unreliable and electrophysiologic studies, at times accompanied by magnetic resonance imaging of the spinal cord, measurement of the circulating creatine phosphokinase concentration, and muscle biopsy, are often necessary to establish the diagnosis. Variants of critical illness polyneuropathy may occur outside the critical care unit. The precise mechanism of these neuromuscular conditions is not known, and further basic research is needed. CONCLUSIONS A variety of neuromuscular conditions complicates SIRS. The identification of these conditions is important in patient management and in rendering a prognosis.

[1]  F. Leijten,et al.  The Role of Polyneuropathy in Motor Convalescence After Prolonged Mechanical Ventilation , 1995 .

[2]  C. M. Wiles,et al.  Critical illness poly-neuropathy following severe hyperpyrexia. , 1995, QJM : monthly journal of the Association of Physicians.

[3]  J. Dhainaut,et al.  Platelet‐activating factor receptor antagonist BN 52021 in the treatment of severe sepsis: A randomized, double‐blind, placebo‐controlled, multicenter clinical trial , 1994 .

[4]  K. Reinhart,et al.  Influence of N‐acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: Results from a prospective, randomized, double‐blind study , 1994, Critical care medicine.

[5]  E. Wijdicks,et al.  The clinical spectrum of critical illness polyneuropathy. , 1994, Mayo Clinic proceedings.

[6]  C. Bolton Muscle weakness and difficulty in weaning from the ventilator in the critical care unit. , 1994, Chest.

[7]  C. Jackson,et al.  Prolonged paralysis due to nondepolarizing neuromuscular blocking agents and corticosteroids , 1994, Muscle & nerve.

[8]  V. Kučinskas,et al.  Low Frequency of the ΔF508 Mutation in Finno-Ugrian and Baltic Populations , 1994 .

[9]  D. Heney,et al.  Increased circulating adhesion molecule concentrations in patients with the systemic inflammatory response syndrome: A prospective cohort study , 1994, Critical care medicine.

[10]  D. Ramsay,et al.  Acute necrotizing myopathy of intensive care: Electrophysiological studies , 1994, Muscle & nerve.

[11]  A. Pestronk,et al.  Rapidly evolving myopathy with myosin‐deficient muscle fibers , 1994, Annals of neurology.

[12]  F. Leijten,et al.  Critical illness polyneuropathy a review of the literature, definition and pathophysiology , 1994, Clinical Neurology and Neurosurgery.

[13]  D. Lange,et al.  Neuromuscular diseases , 2000, Clinical Neurophysiology.

[14]  J. Mendell,et al.  Polyneuropathy complicating bone marrow and solid organ transplantation , 1993, Neurology.

[15]  S. Ludwin,et al.  A Syndrome of Acute Severe Muscle Necrosis in Intensive Care Unit Patients , 1993, Journal of neuropathology and experimental neurology.

[16]  W. Peters,et al.  Neuropathy in burn patients. , 1993, Brain : a journal of neurology.

[17]  A. Ropper,et al.  Acute respiratory failure neuropathy: A variant of critical illness polyneuropathy , 1993, Critical care medicine.

[18]  D. Lacomis,et al.  Acute myopathy and neuropathy in status asthmaticus: Case report and literature review , 1993, Muscle & nerve.

[19]  C. Minetti,et al.  Acute quadriplegic myopathy , 1992, Neurology.

[20]  Y. Kupfer,et al.  Prolonged Weakness after Long-Term Infusion of Vecuronium Bromide , 1992, Annals of Internal Medicine.

[21]  R D Miller,et al.  Persistent paralysis in critically ill patients after long-term administration of vecuronium. , 1992, The New England journal of medicine.

[22]  G. Awerbuch,et al.  Neuromuscular causes of prolonged ventilator dependency , 1992, Muscle & nerve.

[23]  Y. Archibald,et al.  The Electroencephalogram in Sepsis‐Associated Encephalopathy , 1992, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[24]  R. Schellens,et al.  Critical illness polyneuromyopathy after artificial respiration , 1991, Clinical Neurology and Neurosurgery.

[25]  S. Subramony,et al.  Myopathy and prolonged neuromuscular blockade after lung transplant , 1991, Critical care medicine.

[26]  P. Souney,et al.  Pancuronium‐induced prolonged neuromuscular blockade , 1991, Critical care medicine.

[27]  S. Carpenter,et al.  Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment , 1991, Muscle & nerve.

[28]  M. Glauser,et al.  Septic shock: pathogenesis , 1991, The Lancet.

[29]  Prolonged paralysis after treatment with neuromuscular junction blocking agents , 1991, Critical care medicine.

[30]  D. Reid,et al.  Complete ophthalmoplegia as a complication of acute corticosteroid‐ and pancuronium‐associated myopathy , 1991, Neurology.

[31]  W. Sibbald,et al.  Peripheral nerve function in sepsis and multiple organ failure. , 1991, Chest.

[32]  Y. Archibald,et al.  The encephalopathy associated with septic illness. , 1990, Clinical and investigative medicine. Medecine clinique et experimentale.

[33]  R. Zatorre,et al.  Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels. , 1990, The New England journal of medicine.

[34]  T. Kosatsky,et al.  Neurologic sequelae after ingestion of mussels contaminated with domoic acid. , 1990, The New England journal of medicine.

[35]  C. Bolton,et al.  Metabolic changes in human muscle denervation: Topical 31P NMR spectroscopy studies , 1988, Magnetic resonance in medicine.

[36]  C. Bolton,et al.  Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. , 1987, Brain : a journal of neurology.

[37]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[38]  C. Bolton Electrophysiologic studies of critically ill patients , 1987, Muscle & nerve.

[39]  W. Sibbald,et al.  Critically ill polyneuropathy: electrophysiological studies and differentiation from Guillain-Barré syndrome. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[40]  H. Laak,et al.  Neuromuscular complications in patients given pavulon/sr (pancuronium bromide) during artificial ventilation , 1985, Clinical Neurology and Neurosurgery.

[41]  G. Young,et al.  The Encephalopathy of Sepsis , 1985, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[42]  W. Sibbald,et al.  Polyneuropathy in critically ill patients. , 1984, Journal of neurology, neurosurgery, and psychiatry.

[43]  G. H. Clowes,et al.  Muscle proteolysis induced by a circulating peptide in patients with sepsis or trauma. , 1983, The New England journal of medicine.

[44]  C. Marsden,et al.  Postanoxic symptomatic oscillatory myoclonus , 1983, Neurology.

[45]  A. Wernig,et al.  Sprouting and regression of the nerve at the frog neuromuscular junction in normal conditions and after prolonged paralysis with curare , 1980, Journal of neurocytology.

[46]  S. Shafiq,et al.  Acute myopathy with selective lysis of myosin filaments , 1979, Neurology.

[47]  D. Cocchi,et al.  Ultrastructure of somatotrophs of rats with median eminence lesions: studies in basal conditions and after thyrotropin-releasing hormone stimulation. , 1979, Neuroendocrinology.

[48]  A. Bischoff,et al.  [Gentamicin neurotoxicity (polyneuropathy--encephalopathy)]. , 1977, Schweizerische medizinische Wochenschrift.

[49]  P. Helm,et al.  Peripheral neurological problems in the acute burn patient , 1977 .

[50]  I. Feller,et al.  Peripheral polyneuropathy among patients with burns. , 1971, Archives of physical medicine and rehabilitation.

[51]  R. H. Jebsen,et al.  POLYNEUROPATHY IN CHRONIC RENAL INSUFFICIENCY. , 1965, JAMA.

[52]  Mertens Hg [Disseminated neuropathy following coma. On the differentation of so-called toxic polyneuropathy]. , 1961 .